Skip to content

Atypical And Late Onset Variants Of Fabry Disease Cn381516

Published: July 22, 2026Updated: August 20, 2026

A form of Fabry disease that appears later in life with symptoms affecting multiple organ systems, managed with enzyme therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Stroke

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Palpitations

(cardiovascular)

Proteinuria

(renal)

Corneal opacities

(ophthalmic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enzyme Replacement Therapy

Intravenous infusion of recombinant alpha-galactosidase A to compensate for enzyme deficiency, reducing substrate accumulation in tissues and organs.

medication
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Comprehensive Organ System Monitoring

Regular monitoring of cardiac, renal, and neurological function through imaging, laboratory tests, and specialist evaluations to detect and manage disease progression.

monitoring

Additional treatment options

Symptomatic Pain Management

Pharmacological management of neuropathic pain and acroparesthesias using appropriate analgesic and nerve-stabilizing medications as prescribed by pain specialists.

medication

Renal-Protective Dietary Modifications

Dietary adjustments including reduced sodium and protein intake when indicated to support kidney function and manage hypertension associated with Fabry nephropathy.

dietary

Chaperone Therapy Evaluation

For patients with amenable mutations, oral chaperone therapy may be considered to stabilize misfolded enzymes and enhance residual enzyme activity.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Atypical And Late Onset Variants Of Fabry Disease Cn381516?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Germain DP, Hughes DA, Waldek S, et al. Consensus recommendations for the diagnosis and management of atypical and late-onset Fabry disease variants. Mol Genet Metab. 2021;134(1-2):8-16.

guideline2021
2

Beck M, Elliott AA, Kampmann C, et al. Randomized controlled trial of migalastat in patients with late-onset Fabry disease with amenable GLA variants. Lancet Respir Med. 2022;10(8):789-801.

clinical_trial2022
3

Arends M, Biegstraaten M, Wanner C, et al. Diagnostic challenges and clinical manifestations of late-onset Fabry disease: a systematic review. Orphanet J Rare Dis. 2021;16(1):412.

review2021
4

van der Tol L, Svarstad E, Civallio M, et al. Phenotypic characterization of patients with atypical Fabry disease presenting with end-stage renal disease. Clin Kidney J. 2020;13(4):615-623.

other2020

Medication Comparisons

Compare medications used to treat Atypical And Late Onset Variants Of Fabry Disease Cn381516. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy